Jeffrey Meckler - Apr 10, 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey Meckler
Stock symbol
INDP
Transactions as of
Apr 10, 2025
Transactions value $
-$504
Form type
4
Date filed
4/11/2025, 04:15 PM
Previous filing
Nov 26, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Disposed to Issuer -$176 -4.75K -100% $0.04 0 Apr 10, 2025 Common Stock 4.75K $536.00 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$139 -3.75K -100% $0.04 0 Apr 10, 2025 Common Stock 3.75K $24.60 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$30 -813 -100% $0.04 0 Apr 10, 2025 Common Stock 813 $425.60 Direct F1
transaction INDP sStock Option (right to buy) Disposed to Issuer -$56 -1.5K -100% $0.04 0 Apr 10, 2025 Common Stock 1.5K $425.60 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$58 -1.56K -100% $0.04 0 Apr 10, 2025 Common Stock 1.56K $611.20 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer -$46 -1.25K -100% $0.04 0 Apr 10, 2025 Common Stock 1.25K $355.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.